Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas

1

Introduction

00:00 • 2min

2

Andex Mining Jah, a Public Expert in His Own Right

02:05 • 2min

3

The White House Covet Briefings

04:22 • 2min

4

Covet

06:18 • 2min

5

Boosters for the Elderly

08:20 • 2min

6

The Journal of the Prevention of All Samers Disease

10:15 • 2min

7

Are These Drugs Really Going to Work?

12:14 • 2min

8

Medical Chemists in Ukraine - Are They Safe?

13:50 • 2min

9

Drug Development in Ukraine - What's the History?

15:47 • 2min

10

Do You Think It's Going to Be a Long Time?

17:35 • 2min

11

What's Next for Ukranians?

19:23 • 2min

12

Drug Pricing Hearings - What Was the Expectation of a Real Change?

21:14 • 2min

13

What's Happened With Sticker Prices?

23:00 • 2min

14

Drug Rebates - What's Happened Since 20 19?

24:44 • 2min

15

Drug Prices - The Only Real Achievement From Legislators Has Turned Out to Be a Flop

26:28 • 2min

16

Health Care Supply Chain

28:27 • 2min